Huffington Post: Who can get a coronavirus test?
UC expert says screenings will have to be reserved for higher-risk patients
Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases was interviewed by the Huffington Post for a story on who can get tested for coronavirus.
Dr. Carl Fichtenbaum in a lab in the UC Division of Infectious Diseases. Photo credit/Joe Fuqua II/UC Creative + Brand
Dr. Fichtenbaum said until the availability of testing increases, screenings will have to be reserved for higher-risk patients.
Fichtenbaum said that if you have mild symptoms of the virus, the advice is going to be the same whether you have a positive test: “Stay home untll you’re better. Quarantine yourself away from family or roommates or friends. Get rest plenty of liquids. Take some cough syrup or Tylenol for aches and pains.”
Read the full article here.
Dr. Fichtenbaum was also featured in a separate Huffington Post article on how coronavirus tests work. Read that article here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.